NCT01967810 2020-02-25ANG1005 in Patients With Recurrent High-Grade GliomaAngiochem IncPhase 2 Completed73 enrolled
NCT00539344 2014-07-31A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Malignant GliomaAngiochem IncPhase 1 Completed63 enrolled